53 related articles for article (PubMed ID: 38486684)
1. Toxic epidermal necrolysis and Stevens-Johnson syndrome.
Harr T; French LE
Orphanet J Rare Dis; 2010 Dec; 5():39. PubMed ID: 21162721
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of severe adverse cutaneous drug reactions in patients admitted to tertiary care center: A cross-sectional study.
Moshayedi MA; Asilian A; Mokhtari F
Health Sci Rep; 2024 Mar; 7(3):e1969. PubMed ID: 38486684
[TBL] [Abstract][Full Text] [Related]
3. Adverse cutaneous drug reactions: Eight year assessment in hospitalized patients.
Mokhtari F; Nikyar Z; Naeini BA; Esfahani AA; Rahmani S
J Res Med Sci; 2014 Aug; 19(8):720-5. PubMed ID: 25422656
[TBL] [Abstract][Full Text] [Related]
4. A Retrospective Cohort Study of the Management and Outcomes of Children Hospitalized with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis.
Antoon JW; Goldman JL; Shah SS; Lee B
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):244-250.e1. PubMed ID: 29859332
[TBL] [Abstract][Full Text] [Related]
5. Patch testing and cross sensitivity study of adverse cutaneous drug reactions due to anticonvulsants: A preliminary report.
Shiny TN; Mahajan VK; Mehta KS; Chauhan PS; Rawat R; Sharma R
World J Methodol; 2017 Mar; 7(1):25-32. PubMed ID: 28396847
[TBL] [Abstract][Full Text] [Related]
6. Adverse Skin Reactions with Antiepileptic Drugs Using Korea Adverse Event Reporting System Database, 2008-2017.
Kim HK; Kim DY; Bae EK; Kim DW
J Korean Med Sci; 2020 Feb; 35(4):e17. PubMed ID: 31997613
[TBL] [Abstract][Full Text] [Related]
7. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.
Papp A; Sikora S; Evans M; Song D; Kirchhof M; Miliszewski M; Dutz J
Burns; 2018 Jun; 44(4):807-815. PubMed ID: 29627131
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological factors in patients with dermatologic conditions referring to the clinic of traditional Persian Medicine: A cross-sectional study.
Parvizi MM; Fatehi N; Jaladat AM; Gholampour Z; Shahriarirad R; Erfani A
Int J Clin Pract; 2021 Nov; 75(11):e14788. PubMed ID: 34480839
[TBL] [Abstract][Full Text] [Related]
9. Atopic dermatitis in the elderly Caucasian population: diagnostic clinical criteria and review of the literature.
Chello C; Carnicelli G; Sernicola A; Gagliostro N; Paolino G; Di Fraia M; Faina V; Muharremi R; Grieco T
Int J Dermatol; 2020 Jun; 59(6):716-721. PubMed ID: 32311089
[TBL] [Abstract][Full Text] [Related]
10. Genetic and clinical risk factors associated with phenytoin-induced cutaneous adverse drug reactions in Thai population.
Sukasem C; Sririttha S; Tempark T; Klaewsongkram J; Rerkpattanapipat T; Puangpetch A; Boongird A; Chulavatnatol S
Pharmacoepidemiol Drug Saf; 2020 May; 29(5):565-574. PubMed ID: 32134161
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of cutaneous adverse drug reactions.
Mockenhaupt M
Allergol Select; 2017; 1(1):96-108. PubMed ID: 30402608
[TBL] [Abstract][Full Text] [Related]
12. Adverse drug reactions and organ damage: The skin.
Marzano AV; Borghi A; Cugno M
Eur J Intern Med; 2016 Mar; 28():17-24. PubMed ID: 26674736
[TBL] [Abstract][Full Text] [Related]
13. Adverse cutaneous drug eruptions: current understanding.
Hoetzenecker W; Nägeli M; Mehra ET; Jensen AN; Saulite I; Schmid-Grendelmeier P; Guenova E; Cozzio A; French LE
Semin Immunopathol; 2016 Jan; 38(1):75-86. PubMed ID: 26553194
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous adverse drug reactions in Indian population: A systematic review.
Patel TK; Thakkar SH; Sharma D
Indian Dermatol Online J; 2014 Dec; 5(Suppl 2):S76-86. PubMed ID: 25593813
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
